Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cell Physiol ; 237(1): 128-148, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34311499

RESUMO

Glucose metabolism is a mechanism by which energy is produced in form of adenosine triphosphate (ATP) by mitochondria and precursor metabolites are supplied to enable the ultimate enrichment of mature metabolites in the cell. Recently, glycolytic enzymes have been shown to have unconventional but important functions. Among these enzymes, pyruvate kinase M2 (PKM2) plays several roles including having conventional metabolic enzyme activity, and also being a transcriptional regulator and a protein kinase. Compared with the closely related PKM1, PKM2 is highly expressed in cancer cells and embryos, whereas PKM1 is dominant in mature, differentiated cells. Posttranslational modifications such as phosphorylation and acetylation of PKM2 change its cellular functions. In particular, PKM2 can translocate to the nucleus, where it regulates the transcription of many target genes. It is notable that PKM2 also acts as a protein kinase to phosphorylate several substrate proteins. Besides cancer cells and embryonic cells, astrocytes also highly express PKM2, which is crucial for lactate production via expression of lactate dehydrogenase A (LDHA), while mature neurons predominantly express PKM1. The lactate produced in cancer cells promotes tumor progress and that in astrocytes can be supplied to neurons and may act as a major source for neuronal ATP energy production. Thereby, we propose that PKM2 along with its different posttranslational modifications has specific purposes for a variety of cell types, performing unique functions.


Assuntos
Leucemia Mieloide Aguda , Piruvato Quinase , Trifosfato de Adenosina/metabolismo , Linhagem Celular Tumoral , Glicólise/fisiologia , Humanos , Lactatos , Proteínas Quinases/metabolismo , Piruvato Quinase/genética
2.
J Histochem Cytochem ; 50(12): 1659-62, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12486088

RESUMO

The membrane-impermeable chelator CaEDTA was introduced extracellularly among neurons in vivo and in vitro for the purpose of chelating extracellular Zn(2+). Unexpectedly, this treatment caused histochemically reactive Zn(2+) in intracellular compartments to drop rapidly. The same general result was seen with intravesicular Zn(2+), which fell after CaEDTA infusion into the lateral ventricle of the brain, with perikaryal Zn(2+) in Purkinje neurons (in vivo) and with cortical neurons (in vitro). These findings suggest either that the volume of zinc ion efflux and reuptake is higher than previously suspected or that EDTA can enter cells and vesicles. Caution is therefore warranted in attempting to manipulate extracellular or intracellular Zn(2+) selectively.


Assuntos
Quelantes/farmacologia , Ácido Edético/farmacologia , Neurônios/metabolismo , Espermina/análogos & derivados , Zinco/metabolismo , Animais , Encéfalo/metabolismo , Encéfalo/ultraestrutura , Células Cultivadas , Depressão Química , Espaço Extracelular/metabolismo , Histocitoquímica , Injeções Intraventriculares , Líquido Intracelular/metabolismo , Masculino , Microinjeções , Neurônios/ultraestrutura , Doadores de Óxido Nítrico/farmacologia , Óxidos de Nitrogênio , Ratos , Ratos Sprague-Dawley , Espermina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...